US EditionPublished • loading... • Updated
Cellares and City of Hope Sign Deal to Automate Solid Tumor CAR T Cell Therapy Manufacturing
Cellares and City of Hope, one of the largest cancer R&D treatment organizations in the U.S., said they will collaborate to evaluate automated manufacturing of City of Hope’s investigational gene-modified CAR T cell therapy targeting glioblastoma multiforme, an aggressive solid tumor brain cancer with limited treatment options. City of Hope is a leader in CAR T for glioblastoma and was the first to administer CAR T cell therapy locally in the br…
1 Articles
1 Articles
Cellares and City of Hope Sign Deal to Automate Solid Tumor CAR T Cell Therapy Manufacturing
Cellares and City of Hope, one of the largest cancer R&D treatment organizations in the U.S., said they will collaborate to evaluate automated manufacturing of City of Hope’s investigational gene-modified CAR T cell therapy targeting glioblastoma multiforme, an aggressive solid tumor brain cancer with limited treatment options. City of Hope is a leader in CAR T for glioblastoma and was the first to administer CAR T cell therapy locally in the br…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
